Effects of adding a leukotriene antagonist or a long-acting beta2-agonist in asthmatic patients with the glycine-16 beta2-adrenoceptor genotype

This publication has 30 references indexed in Scilit:

• Measuring exhaled nitric oxide: not only a matter of how--but also why--should we do it?
  European Respiratory Journal, 1998
• Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced Bronchoconstriction
  New England Journal of Medicine, 1998
• Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.
  Thorax, 1998
• Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
  New England Journal of Medicine, 1997
• The glutamine 27 β2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families
  Journal of Allergy and Clinical Immunology, 1997
• Airway Subsensitivity with Long-Acting ??2-Agonists Is There Cause for Concern?
  Drug Safety, 1997
• 270 Effect of treatment with zafirlukast (ACCOLATE™) on brobchial hyperresponsiveness in patients with mild-to-moderate asthma
  Journal of Allergy and Clinical Immunology, 1996
• Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients.
  Thorax, 1995
• Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
  The Lancet, 1994
• Measurement of airway responsiveness to methacholine: relative importance of the precision of drug delivery and the method of assessing response.
  Thorax, 1993